Office of Generic Drugs | Offices and Divisions
Immediate Office
Phone: 240-402-7920 Fax: 301-595-1147
Sally Choe, Ph.D., Director, Office of Generic Drugs (OGD)
Iilun C. Murphy, M.D., Deputy Director of Clinical and Regulatory Affairs, which includes Communications Staff, Clinical Safety Surveillance Staff, and various Immediate Office positions
Janet McGinn, D.V.M., Deputy Director of Operations, which includes the Program Management Analysis Staff, Generic Regulatory Affairs Team, and various Immediate Office positions.
William Chong, M.D., Associate Director of Clinical Affairs
Sarah Ibrahim, Ph.D., Associate Director of Global Generic Drug Affairs
Samir Shaikh, M.B.A., Associate Director of Knowledge Management
Office of Bioequivalence (OB)
Partha Roy, Ph.D., Director, Office of Bioequivalence, which includes the three Divisions of Bioequivalence and the Division of Clinical Review
Nilufer Tampal, Ph.D., Acting Deputy Director
Kimberly Witzmann, M.D., Acting Deputy Director
Office of Generic Drug Policy (OGDP)
Maryll W. Toufanian, J.D., Director, Office of Generic Drug Policy, which includes the Division of Policy Development and the Division of Legal and Regulatory Support
Kristin Davis, J.D., Deputy Director
Office of Research and Standards (ORS)
Rob Lionberger, Ph.D., Director, Office of Research and Standards, which includes the Division of Therapeutic Performance and the Division of Quantitative Methods and Modeling
Lei Zhang, Ph.D., Deputy Director
Office of Regulatory Operations (ORO)
Edward “Ted” Sherwood, Director, Office of Regulatory Operations, which includes the Division of Filing Review, the Division of Labeling Review, the Division of Project Management, and the Division of Quality Management Systems.
LCDR Malik Imam, Pharm.D., Deputy Director